FDA approves VR headset for amblyopia therapy from Luminopia

Luminopia One is one of few digital therapeutics to receive FDA approval via the de novo pathway, and it is the first for amblyopia, and for a neuro-visual disorder in general.

Results of phase 2 study of AR-1105 in macular edema, secondary to retinal vein occlusion

In his presentation at ASRS 2021, Dr. Michael Singer divulges the results of the phase 2 study of formulations used to decrease macular edema in patients with retinal vein occlusion.

Unpacking rho-kinase inhibition as a potential therapy for proliferative vitreoretinopathy

Leo Kim, MD, PhD, discusses his presentation at ASRS 2021, entitled "Rho-kinase inhibition on an in vitro patient-derived model of proliferative vitreoretinopathy."